drugset

drugset / Trial / NCT00002352

A Study of Lobucavir in Patients With AIDS

NCT00002352 ↗

Completed 30 enrolled Bristol-Myers Squibb

Treatment

Summary

The purpose of this study is to see if lobucavir is a safe and effective treatment for cytomegalovirus in patients with AIDS.

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lobucavir	Small molecule	—	Oral

Indications